Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 89
2011 155
2012 186
2013 253
2014 1020
2015 3526
2016 6839
2017 10336
2018 3169
2019 743
2020 418
2021 152
Text availability
Article attribute
Article type
Publication date

Search Results

26,008 results
Results by year
Filters applied: . Clear all
Page 1
Multidisciplinary clinics in prostate cancer.
De B, Kuban DA, Tang C. De B, et al. Oncotarget. 2021 Jul 20;12(15):1553-1554. doi: 10.18632/oncotarget.27984. eCollection 2021 Jul 20. Oncotarget. 2021. PMID: 34316333 Free PMC article. No abstract available.
The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma.
Khushman M, Prodduturvar P, Mneimneh W, Zotto VD, Akbar S, Grimm L, Rider P, Hunter J, Alkharabsheh O, Patel GK, Fabregas JC, Singh AP. Khushman M, et al. Oncotarget. 2021 Jul 20;12(15):1490-1498. doi: 10.18632/oncotarget.28025. eCollection 2021 Jul 20. Oncotarget. 2021. PMID: 34316329 Free PMC article.
Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis.
Mokhtari RB, Qorri B, Baluch N, Sparaneo A, Fabrizio FP, Muscarella LA, Tyker A, Kumar S, Cheng HM, Szewczuk MR, Das B, Yeger H. Mokhtari RB, et al. Oncotarget. 2021 Jul 20;12(15):1470-1489. doi: 10.18632/oncotarget.28011. eCollection 2021 Jul 20. Oncotarget. 2021. PMID: 34316328 Free PMC article.
26,008 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page